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Foreword
The Swiss Academy of Sciences (SCNAT) 
advocates research in a mutually trustful 
atmosphere. It is therefore with great pleas-
ure that it makes available to interested 
stakeholders – providers and users alike – 
this example of an Agreement on Access 
and Benefit-sharing (ABS) with contractual 
clauses. The Agreement is meant to serve as 
a tool for trustful, fair and transparent nego-
tiations of ABS contracts and to actively sup-
port the implementation of ABS regulations.
The Agreement focuses on academic, 
mainly non-commercial research. The 
Swiss Academy of Sciences firmly believes 
that non-commercial research is essential 
to achieve the goals of the Convention on 
Biological Diversity (CBD), the conservation 
and the sustainable use of biological diver-
sity. Moreover, such research generates 
(non-monetary) benefits that contribute to 
education, to the advancement of knowl-
edge and to technology transfer. By keeping 
in mind these premises, the Swiss Academy 
of Sciences has elaborated this Agreement, 
with substantial input and support from 
national and international partners. 
The proposed set of model clauses allows to 
set up a contract that is adapted to the indi-
vidual situation and that is mutually agreed 
upon by the negotiation partners. 
The Agreement aims at creating transpar-
ent and legally secure relations between 
users and providers of genetic resources 
and associated traditional knowledge. The 
suggested terms and clauses are intended 
to meet the needs of both, the providers of 
the genetic resources and the researchers 
seeking access, and to ensure fair and equi-
table sharing of benefits. Its ultimate goal 
is to ease the negotiations of the mutually 
agreed terms, to enhance mutual trust, and 
to prevent unnecessary transaction costs in 
its negotiation and implementation.
The Swiss Academy of Sciences wishes 
and hopes that the Agreement contributes 
to facilitating access to genetic resources 
and associated traditional knowledge by 
academic research and to fair and equita-
ble sharing of the benefits related to the 
research process. 
 
Marcel Tanner
President SCNAT
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Introduction 
This document contains a toolbox to set up 
an agreement on mutually agreed terms 
for access to genetic resources and tradi-
tional knowledge associated with genetic 
resources (associated traditional knowl-
edge) and the sharing of benefits resulting 
from their utilization. It is designed for the 
use by providers of genetic resources and 
associated traditional knowledge and aca-
demic researchers.
The sample agreement is set up according to 
the provisions on access and benefit-shar-
ing of the Convention on Biological Diver-
sity and of the Nagoya Protocol. It is mainly 
based on Articles 2 (use of terms), 5.1 (fair 
and equitable benefit-sharing), 6 (access 
to genetic resources) and 7 (access to tra-
ditional knowledge associated to genetic 
resources) of the Nagoya Protocol. It con-
tains model contractual clauses according 
to Article 19.1 of the Nagoya Protocol. 
It can be used in various cases of biodi-
versity research: research in systematics, 
ecology and evolution; identification and 
isolation of active compounds; and genetic 
research. Likewise, it can be adapted to dif-
ferent needs of providers and users.
To allow for this, the Agreement is availa-
ble free of charge as Word document. You 
may adapt it to your needs, reproduce or 
share the original or the adapted version, 
under the condition that there is no mon-
etary advantage linked to the transfer, and 
that the recipient is bound to the same con-
ditions (Creative Commons License 4.0). 
The Agreement serves as a template and 
could be applied to fill the gap where no 
national tools are available or in cases where 
agreements focus on commercial activities 
and are not applicable to academic research. 
The proposed text may also be used as a 
checklist for items that need to be agreed 
upon when negotiating access to genetic 
resources and benefit-sharing for academic 
research, or as inspiration for providers that 
draft standard contracts. 
This model ABS-Agreement cannot replace 
legal requirements in the country provid-
ing genetic resources and/or associated 
traditional knowledge, nor in the country 
where such resources or such knowledge 
are utilized. All users should be aware that 
any ABS contract has to respect the access 
and benefit-sharing legislation or regulatory 
requirements of both, the provider and the 
user country.
Suggestion and feedback by users of this tool 
are most welcome. Write to abs@scnat.ch
Concept
The Agreement is adapted to the specific 
situation of academic, mainly non-commer-
cial research sponsored by public funding. 
Its basic premise is that the mutually agreed 
terms, as stipulated in Article 15 of the Con-
vention on Biological Diversity and Article 
6 of the Nagoya Protocol, are a bilateral 
contract concluded between providers and 
users, resulting from their fair negotiations 
on the terms of access and benefit-sharing.
It encourages involved parties to take 
account of each other’s specific needs and 
circumstances. 
We assume the following basic scenario:
 – The resources are accessed by a 
researcher/research team under the lead 
and responsibility of a research institute.
 – The research purpose is primarly 
non-commercial, aiming at providing 
publicly available results. Therefore, the 
research results have to be published, 
according to good scientific practice.
 – Unexpected research results might spark 
reflections towards their utilization in a 
commercial context.
 – Benefits are non-monetary as a rule. 
They usually accrue during the research 
process.
The Agreement takes account of various 
research activities by proposing options for 
the following conditions: 
 – Different access situations (e.g. access to 
genetic resources vs. access to 
 associated traditional knowledge; access 
to specified taxa vs. the need to identify 
the samples after collection); 
 – Different models of research 
 cooperation;
 – Diverse needs of the provider to monitor 
the implementation of the agreement;
 – Specific aspects of academic research, 
such as the need to publish results and 
the exchange of data, storage and 
accessibility of samples and so on. 
98 Swiss Academies Reports, Vol. 11, No 3, 2016Agreement on Access and Benefit-sharing for Non-commercial Research
How to use this toolbox  
to set up your Mutually Agreed Terms
This model agreement aims at covering all 
issues that might arise in the relationship 
between providers and academic research-
ers with a non-commercial research intent. 
It is set up as a toolbox. This enables the 
involved parties to compose a contract 
on mutually agreed terms tailored to their 
needs. We recommend that both parties 
possess the full text of the Agreement in 
order to foster discussions on options and 
to seek solutions to disagreements that 
might arise.
The Agreement consists of an explanatory 
part (left column) and different types of 
clauses (right column) consisting of: 
 – General clauses. This includes the 
preamble and the definition of terms 
(clause 1); 
 – Clauses on substantive issues  
(clauses 5 to 16); 
 – Clauses on procedural matters  
(clauses 17 to 19). 
The clauses on substantive issues as a rule 
offer two or more options to be selected by 
the parties according to the situation and 
their wishes. 
The first paragraph of each clause (marked 
blue) is considered a basic item. Assembling 
these basic clauses will form a fully func-
tional contract for simple non-commercial 
research situations. The full, cohesive text 
of such simple Mutually Argeed Terms that 
the authors propose is available in Annex III. 
In some cases the options stand for different 
situations of access. Here a choice between 
different options has to be made. 
In more complex situations, each agreement 
must be compiled according to the specific 
needs of the parties engaged in the nego-
tiations. 
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Comments
The Agreement is designed to support aca-
demic, mainly non-commercial research, 
such as research in taxonomy, ecology, 
biochemistry and genetics, to foster con-
servation and the environmentally sound 
and sustainable use of genetic resources, 
and to ensure the fair and equitable shar-
ing of benefits resulting from the research 
in Genetic Resources and Associated Tradi-
tional Knowledge. 
If the Provider is a holder of Associated Tra-
ditional Knowledge, a separate Agreement 
between researchers (as the User) and the 
holder of Associated Traditional Knowledge 
(individual, community, legitimate represent-
ative of the community) needs to be con-
cluded (see Annex II for elements to include). 
Agreement:  
Clauses and Options 
Preamble
 
The objective of this Agreement is to pro-
vide a sound basis for cooperation, trans-
parency, communication and trust between 
the parties to the Agreement, taking account 
of the concerns of both, Providers and Users 
of genetic resources. 
Its purpose is to define the Mutually Agreed 
Terms between its parties relating to access 
to and utilization of the Genetic Resources 
as well as the sharing of benefits resulting 
from their Utilization in accordance with the 
Nagoya Protocol to the Convention on Biolo-
gical Diversity. 
Option 1
As the User seeks access to Traditional Knowl-
edge Associated to Genetic Resources, he/
she will conclude an ancillary agreement with 
the holder(s) of Associated Traditional Knowl-
edge, according to the domestic ABS regula-
tory requirements of the provider country.
Option 2 
As the Genetic Resources to be accessed are 
situated on private land/a collectively owned 
territory, or are in private property, an ancil-
lary agreement will be concluded with the 
owner, according to the domestic ABS regu-
latory requirements of the Provider Country. 
The Agreement has been drafted as a basis 
for negotiations with the competent author-
ity that is designated by the domestic ABS 
regulation (“provider”) as the party to the 
Agreement. It is responsible for fulfilling the 
obligations under Clause 11 of this Agree-
ment. 
The Agreement could also be applied in 
negotiations with competent institutions 
of delegated entities such as e.g. federal or 
decentralized governments. 
Selected elements may also be used for 
ancillary agreements with holders of Asso-
ciated Traditional Knowledge and/or private 
owners of Genetic Resources (see Annex II).
The User can only be a research institution; 
an individual researcher may act on behalf 
of it.
The data of both the User and Provider 
serve as reference and contact point in the 
communication between the parties. The 
indicated research institution shall be held 
as the responsible body during the term 
of the Agreement. The competent national 
agency will be responsible for maintaining 
the Agreement.
 
Parties to the Agreement 
The Agreement is entered into on  
[→  INSERT the date] 
by and between
[→  INSERT the name and details  
of the following: 
 – State and Institution (Competent  National 
Authority, according to Article 13 of the 
Nagoya Protocol and the domestic 
regulations of the Provider)
 – The contact person responsible for  
the implementation of the Agreement  
on behalf of the institution]
together hereinafter referred to as  
the “Provider”, and
[→  INSERT the name and details of 
 – The responsible research institution
 – The representative of the research 
institution responsible for the implemen-
tation of the Agreement]
Together hereinafter referred to as the 
“User”.
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This clause contains definitions of the terms 
used in the Agreement. The Parties are how-
ever free to replace or customize the terms in 
accordance with their needs and in particu-
lar in accordance with the planned research 
activities. They can also opt between nar-
row or broader definitions by excluding or 
including different options.
The terms defined in this clause are marked 
by uppercase initials throughout the Agree-
ment. 
Option 1.3.1 is identical to Article 2(e) of the 
Nagoya Protocol. It is the option that should 
in principle be used. 
In addition there are two more options that 
differ in scope: 
In the second option, the derivative (and 
potential rights associated) is linked to the 
accessed genetic resource.
1  Use of Terms in the Agreement
This Agreement uses the terms as defined 
in Article 2 of the Nagoya Protocol, unless 
otherwise defined in this Agreement. 
1.1 Genetic Resources
Genetic Resources means any material of 
plant, animal, microbial or other origin con-
taining functional units of heredity and of 
actual or potential value (Article 2.10 of the 
Convention on Biological Diversity). 
1.2 Utilization of Genetic Resources
Utilization of Genetic Resources means to 
conduct research and development on the 
genetic and/or biochemical composition of 
genetic resources, including through the 
application of biotechnology (Article 2 [c] 
Nagoya Protocol). 
1.3 Derivatives
Option 1.3.1 
“Derivative” means a naturally occurring 
biochemical compound resulting from the 
genetic expression or metabolism of biolog-
ical or genetic resources, even if it does not 
contain functional units of heredity (Art. 2 [e] 
Nagoya Protocol).
Option 1.3.2
Derivative means a naturally occurring 
biochemical compound resulting from the 
The third option is much broader, including 
a biochemical compound even if separated 
from the Genetic Resources. This means that 
also utilization (i.e. research and develop-
ment) conducted on the biochemical com-
pound that have been accessed in extracted 
form in the country of origin/ from the pro-
ducers, fall under the agreement. 
This clause contains activities that might be 
important for a later commercialization, but 
are not yet a commercialization in them-
selves. They are included because such 
actions by the User – if not properly agreed 
upon – may generate mistrust and misunder-
standings (see comments to clause 7). 
Square brackets [ ] indicate parts that can be 
left out or integrated, according to the given 
situation and needs.
The Prior Informed Consent may consist in 
a research permit, if so declared by the Pro-
vider. 
genetic expression or metabolism of biolog-
ical or genetic resources, contained in the 
Genetic Resource accessed, even if it does 
not contain functional units of heredity. 
Option 1.3.3
Derivative means a naturally occurring 
biochemical compound resulting from the 
genetic expression or metabolism of bio-
logical or genetic resources, even if it does 
not contain functional units of heredity, 
accessed in the country of origin/from the 
producers of the derivative, also if separated 
from the Genetic Resource. 
1.4 Commercial Intent 
Within the scope of this Agreement, Com-
mercial Intent is indicated by actions such 
as filing a patent application, obtaining 
intellectual property rights or other tangi-
ble or intangible rights; or the transfer of the 
Genetic Resources to a for-profit organiza-
tion.
1.5 Commercialization
Commercialization means the generation of 
any kind of economic benefits from utilized 
Genetic Resources [and/or Associated Tra-
ditional Knowledge]. It means in particular 
any sale, lease, licensing of utilized Genetic 
Resources, as well as applying for market 
admission/marketing of the Products gen-
erated thereof. 
1.6 Prior Informed Consent 
Prior Informed Consent means the unilateral 
declaration of the Provider that he/she has 
been informed about the planned research 
and that he/she is willing to provide the 
required access to Genetic Resources. 
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The Mutually Agreed Terms may be con-
tained in one document, or in a main doc-
ument and ancillary agreements with spe-
cific stakeholder groups, such as holders of 
Associated Traditional Knowledge or private 
owners of Genetic Resources. 
 
Definition by the Intergovernmental Com-
mittee on Intellectual Property and Genetic 
Resources, Traditional Knowledge and Folk-
lore (IGC) WIPO. Accessible at 
www.wipo.int/tk/en/resources/ 
glossary.html#50
1.7 Mutually Agreed Terms 
The Mutually Agreed Terms are an agree-
ment negotiated between the Provider and 
the User of the Genetic Resources [and/or 
holders of Associated Traditional Knowl-
edge] according to the ABS regulatory 
requirements of the country providing the 
resources. The Mutually Agreed Terms regu-
late conditions for the access to the Genetic 
Resources [and/or to their Associated Tradi-
tional Knowledge] and the fair and equita-
ble sharing of benefits that result from their 
use. They are adapted to the specific access 
situation
1.8 Traditional Knowledge Associated  
with Genetic Resources 
Associated Traditional Knowledge is knowl-
edge resulting from intellectual activity in a 
traditional context that is specific or gen-
eral in its relationship to genetic resources. 
It includes know-how, practices, skills 
and innovations. It can be found in a wide 
variety of contexts, including: agricultural 
knowledge; scientific knowledge, technical 
knowledge, ecological knowledge, medicinal 
knowledge, including related medicines and 
remedies; and biodiversity-related knowl-
edge. 
1.9 Product
Product means the result produced, 
obtained, extracted or derived from the utili-
zation of the Genetic Resource [and Associ-
ated Traditional Knowledge]. 
1.10 Provider
The Provider is the national competent 
authority designated according to Article 
13.2 of the Nagoya Protocol. In some cases 
 
 
The provider country may have its own, spe-
cific definition of the term. 
 
Regarding the relation with Third Parties see 
clause 8. 
 
Article 15.5 of the Convention on Biodiversity 
and Article 6.1 of the Nagoya Protocol state 
that access to the genetic resource shall 
be subject to prior informed consent of the 
Party providing access. Note that Parties are 
free to waive the requirement of their prior 
informed consent for accessing the genetic 
resources. In these cases there are no ABS 
requirements but there might be other con-
ditions for access. 
Clause 2 provides two options for the prior 
informed consent: 
the Provider might also be an institution 
established in accordance with domestic 
regulations of the provider country that is 
competent and responsible for the negoti-
ation and conclusion of this ABS contract. 
The provider is represented by the contact 
person responsible for the implementation 
of the Agreement on behalf of the institution. 
1.11 User 
The User is the research institution respon-
sible for the execution of the research pro-
ject. It may be represented by the person 
leading the project. 
1.12 Third Party
Third Party means any person or institution 
other than the Provider, the User and any 
collaborator under their control or supervi-
sion. 
1.13 Unauthorized Person
Unauthorized Person means any person 
that came into possession of the Genetic 
Resources without the authorization of the 
User and/or the Provider.
2  Prior Informed Consent
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The first option applies to cases where 
access to genetic resources is subject to a 
formal Prior Informed Consent by the Pro-
vider, based on the submitted research pro-
ject. The project should contain information 
on resources to be accessed, planned utili-
zation, prospective or intended benefits to 
be shared.
 
Prior informed consent can also consist in a 
research permit, if so intended by the Provider.
 
This option applies to cases where the Pro-
vider determined that the Prior Informed 
Consent is included in the Mutually Agreed 
Terms. 
 
Here, the Parties may list names of species 
or strains of the material to be accessed or 
any other attributes that may help to define 
the genetic resources.
 
The list may include identified and uniden-
tified species. If there are unidentified spe-
cies/strains in the submitted list, option 3.3 
may apply, too. 
Option 2.1
The Agreement is based on the Prior 
Informed Consent issued beforehand by 
the Provider to the User granting access to 
the Genetic Resources concerned. The doc-
ument on Prior Informed Consent [and the 
research project it is based on] is attached 
to this Agreement and is considered its inte-
gral part. 
Option 2.2 
The Provider hereby confirms that he/she 
has been informed on the research pro-
ject by the User and consents to provide 
access to genetic resources in-situ and/or 
ex-situ necessary to carry out the research 
in accordance with the research project 
attached to this Agreement. He/she herewith 
gives his/her Prior Informed Consent.
3  Genetic Resources  
to be accessed
Option 3.1
The User shall have access to the following 
Genetic Resource(s):
[→  INSERT list of the Genetic Resources to 
be accessed (Scientific name, place of col-
lection)].
Option 3.2
Since the species/strains present at the col-
lection site are not known to the User at the 
time of concluding this Agreement, a general 
account of species/strains most likely to be 
collected is given in Annex [→  INSERT XX] of 
this Agreement.
 
For the meaning of the term “utilization” see 
clause 1.2.
For the definition of the term see clause 1.4.   
Option 3.3
1. A list of the collected samples according 
to the researcher’s field-notes is pre-
sented to the Provider within [→  INSERT 
XX] months after having gathered the 
samples.
2. If the collected samples cannot be iden-
tified within the above prescribed period, 
their identification has to be shared with 
the User as soon as it is available.
4  Utilization
 
Option 4.1
Genetic Resources [and Associated Tradi-
tional Knowledge] may be utilized non-com-
mercially, including for academic research 
and collections, and for training, teaching 
and education.
Option 4.2
The Genetic Resources may be used to con-
duct research and development on their 
genetic and/or biochemical composition. 
Option 4.3
The Genetic Resources shall be used exclu-
sively for the following purposes: [→  INSERT 
allowed activities and/or uses].
5  Commercial Intent 
 
Option 5.1 
If the Utilization of the Genetic Resources 
[and Associated Traditional Knowledge] 
changes from non-commercial research to 
research with a Commercial Intent, such 
change requires a new Prior Informed Con-
sent in writing issued by the Provider. The 
1918 Swiss Academies Reports, Vol. 11, No 3, 2016Agreement on Access and Benefit-sharing for Non-commercial Research
Option 5.2 answers the need of re sear-
chers to being able to patent the results of 
research without delay. In the case of a later 
commercialization, clause 6, either option 6.1 
or 6.2 are applicable, as decided upon by the 
parties.  
For the definition of the term “commerciali-
zation” see clause 1.5.
Option 6.2 is in favor of commercialization; 
its rationale is to facilitate the generation of 
economic benefits and their sharing with the 
Provider of the Genetic Resources. 
The rationale of this clause is that patenting 
of the research results does not mean that 
these can/will be used in a commercial con-
text. This is why patenting and commerciali-
zation are treated as two different issues.
 
The options answer to different interests and 
needs of Providers and Users respectively. 
terms for the new Utilization shall be subject 
to a separate agreement (Mutually Agreed 
Terms) between the involved parties.
Option 5.2
The Provider herewith consents to change 
from non-commercial research to research 
with a Commercial Intent in the utilization of 
the Genetic Resources; in particular to the 
patenting of the research results.
6  Commercialization 
Option 6.1 
Any Commercialization of the Genetic 
Resources shall require a new Prior Informed 
Consent in writing issued by the Provider. 
The terms of such Commercialization shall 
be subject to a separate agreement (Mutu-
ally Agreed Terms) between the involved 
parties. 
Option 6.2
The Provider herewith consents to the Utili-
zation with Commercial Intent and the Com-
mercialization of the product resulting from 
the Utilization of the Genetic Resources. In 
the case of Commercialization, the User shall 
provide [→   INSERT percentage] of the net 
profit to the Provider.
7  Intellectual Property Rights 
 
 
Option 7.2 takes into account that – given 
the frequently competitive situation in 
research – a patent needs to be applied 
for as promptly as possible. The interest of 
the Provider can be protected by choosing 
option 1 in clause 6, asking for new PIC in the 
case of commercialization.
The additional Mutually Agreed Terms deter-
mine inventorship and ownership taking into 
account the role and contributions of the 
persons involved in the development of the 
invention as well as the contribution of the 
Genetic Resources. Ownership shall reflect 
inventorship. In the case of a jointly owned 
invention between the Provider and the User, 
the invention agreement provides for fair and 
equitable sharing of patent costs, income, 
and invention management responsibilities.
This Option answers to the situation that the 
User is not interested in obtaining an Intel-
lectual Property Right, but the Provider is. 
In this case, the User – as the innovator – 
has to apply for the patent, the Provider not 
being entitled to do so. Details are to be reg-
ulated in an ancillary agreement regulating 
in particular the patent office for the applica-
tion, distribution of costs for the application; 
ownership of the intellectual property rights, 
invention management responsibilities, and 
the distribution of potential benefits.
 
Option 7.1
The User shall not claim any Intellectual 
Property Rights over the Genetic Resources 
[in the form received].
Option 7.2 
The Provider agrees that the User applies for 
Intellectual Property Rights for the results of 
his research. 
Option 7.3
If the User wants to obtain Intellectual Prop-
erty Rights on research results such act shall 
be treated as a Commercial Intent. An addi-
tional agreement (MAT) shall be negotiated 
in good faith under clause 5.1 of the present 
Agreement. 
Option 7.4
If the Provider wishes to obtain Intellectual 
Property Rights, the Provider has the right to 
propose/require the application for IPRs by 
the User. Details are regulated in an ancillary 
agreement. 
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It is important that the User passes on the 
terms of this Agreement to Third Parties in 
order to avoid uncontrolled flow of genetic 
resources.
 
If institutions or persons are appointed for 
specific analytical and technical auxiliary 
work, the conditions of this Agreement must 
be included in the contract regulating the 
cooperation.
Options 8.1–8.3 establish different levels of 
control. Parties should include those that 
reflect the appropriate level of control in 
accordance with their needs.
8  Transfer of Genetic Resources  
[and Associated Traditional  
Knowledge] to Third Parties 
 
Option 8.1 
Transfer of the Genetic Resources [and of 
Associated Traditional Knowledge] for the 
purposes of academic research and collec-
tions, and for training, teaching and edu-
cation, or any other non-commercial activ-
ities is allowed under the condition that the 
User ensures that the subsequent person or 
institution (Third Party) is informed about the 
provisions under this Agreement and under-
takes to pass on the Genetic Resources [and 
Associated Traditional Knowledge] under the 
same obligations to any further recipient. 
Option 8.2 
The User shall require the Third Party to 
sign an agreement containing identical obli-
gations on Utilization and transfer of the 
Genetic Resources [and their Associated 
Traditional Knowledge] as set out in this 
Agreement.
Option 8.3 
The User delivers to the Provider annually 
[→  INSERT date] a list of the Third Parties 
to whom the Genetic Resources [and Asso-
ciated Traditional Knowledge] have been 
transferred.
 
Option 8.5 is an extremely limiting meas-
ure. It is meant primarily in cases dealing 
with Associated Traditional Knowledge. We 
assume that the Provider may have an inter-
est to keep knowledge secret and therefore 
may want strict control on any further trans-
fer of the Genetic Resources and Associated 
Traditional Knowledge.
Clause 9 is related to clause 8. It proposes 
different levels of control of resources stored 
in ex-situ collections. 
Option 9.1 refers to e.g. living genetic 
resources planted in a Botanic Garden. 
 
 
The handling of the Genetic Resources after 
the termination of the research is treated in 
clause 16. 
Option 8.4
The User shall maintain retrievable records 
of any transfer of the Genetic Resources 
[and Associated Traditional Knowledge] to 
Third Parties under the conditions corre-
sponding to this Agreement.
Option 8.5
The Genetic Resources [and their Associ-
ated Traditional Knowledge] may be trans-
ferred to Third Parties only after having 
obtained the written consent of the Pro-
vider. Exempted is a temporary transfer of 
the Genetic Resources to taxonomic special-
ists for scientific identification.
9  Storage of Genetic Resources  
 
Option 9.1
The User is entitled to deposit the Genetic 
Resources in collections that are accessible 
for the public as well as for research pur-
poses.
Option 9.2 
The User is entitled to deposit the Genetic 
Resources in collections that are accessible 
without restrictions for research purposes 
such as herbaria and culture collections. 
Option 9.3 
The special conditions or restrictions 
 r egarding the Utilization or storage of the 
Genetic Resources agreed upon have to 
be clearly stated on the label or otherwise 
linked to any samples, including the indica-
tion of where the information concerning the 
special conditions/restrictions can be found.
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The sharing of benefits resulting from the 
Utilization of Genetic Resources and Asso-
ciated Traditional Knowledge is one of the 
core requirements of ABS. The sharing 
of non-monetary benefits accruing from 
research is to be seen as a counterpart 
to the Providers’ obligation to promote 
research for conservation and sustainable 
use of biological diversity. 
 
Clause 10 contains a minimal standard of 
benefits that correspond to the customary 
standard of good scientific practice and in 
the authors view should always be shared 
if applicable.
Parties to the Agreement are encouraged 
to include additional benefits as defined 
in the options 10.1 to 10.4 and in the list of 
non-monetary benefits, as specified in the 
Nagoya Protocol and the Bonn Guidelines, 
and annexed to this document (Annex I). 
Your choice of benefits may be included in 
clause 10 of the Agreement. The Parties are 
free to go beyond the listed benefits. 
10 Benefit-sharing
The following benefits arising from the uti-
lization of the Genetic Resources [and/or 
Associated Traditional Knowledge] shall be 
shared fairly and equitably by the User.
 –  Acknowledgment of the source of Genetic 
Resources [and Associated Traditional 
Knowledge] 
 · In case of publication or oral pres-
entation of the research results, full 
acknowledgement shall be given to 
the source of the Genetic Resource. 
 · In the case of Associated Traditional 
Knowledge, the research results pub-
lished or presented orally will include 
full acknowledgement of the source, if 
so required by the Provider.
 –  Sharing the results of the research 
 · The Provider will receive a copy of all 
publications. 
 · Research results will be communicated 
to involved stakeholders (e.g. commu-
nities, indigenous people) in an ade-
quate manner and according to rea-
sonable requirements of the Provider;
 · Duplicate specimens will be shared 
with the repository in the provider 
country in accordance with good sci-
entific practice.
In addition, the User agrees to share the fol-
lowing benefits:
Insert a detailed lists of benefits here or in 
an annex [→  INSERT Annex XX].
 
This provision has the purpose to establish 
a long-term access to data generated by the 
User for the Provider, which goes beyond 
the information that can be found in pub-
lications. It is up to the Provider to spell out 
the information of vital interest for him/her. 
This separate agreement should contain the 
precise description of the information/data 
required and the manner of the data trans-
fer, such as time period, communication 
means, as well as the use made of the data. 
Parties to the Agreement should account for 
potential barriers that transfer of data may 
bring along and regulate it as detailed as 
possible, e.g. to define the particular stand-
ard to be used. If there is a language bar-
rier between the Provider and the User, the 
Parties should define the official language 
to operate with.
Option 10.1 Education and Training 
The User contributes as follows to education 
and training of students/staff of the provider 
country [→  INSERT]. 
Option 10.2 Cooperation with research 
institutes 
The User will cooperate with the following 
research institutes in the provider country 
[→  INSERT].
Option 10.3 Data Sharing with research 
partners 
Given the cooperative approach of the 
research, access to and the use of the data 
among the research partners is agreed upon 
in a separate agreement. It is annexed to this 
Agreement [→  INSERT Annex XX] and forms 
its integral part.
Option 10.4 Data Sharing with the Provider 
1. Access to and the use of the data by the 
Provider is agreed upon in a separate 
agreement. It is annexed to this Agree-
ment [→  INSERT Annex XX] and forms its 
integral part. 
2. The Provider agrees that for using the 
data in his own research, he needs the 
consent of the User.
2524 Swiss Academies Reports, Vol. 11, No 3, 2016Agreement on Access and Benefit-sharing for Non-commercial Research
Different options regarding the Providers’ 
right to obtain information on the state of 
research are defined in clause 13 (Reporting). 
 
By performing part of the analyses in the 
provider country, researchers in the provider 
country have the opportunity to be fully 
integrated in the research. However, we pre-
fer to treat the provision as a “right of the 
Provider” rather than as a “Benefit-sharing” 
arrangement due to the fact that such right 
is highly dependent on the technical capac-
ity of the Provider.
This option applies to the scenario that 
unforeseen research results show a poten-
tial for commercialization, and the User has 
no interest to make use of this. See option 
7.4. 
11  Rights and Obligations  
of the Provider 
1. The Provider is the responsible contact 
point for the User for the entire duration 
of the present Agreement. 
2. The Provider has the obligation to facili-
tate access to the Genetic Resources. This 
includes the facilitation of the acquisition 
of other permits required in accordance 
with the relevant national or regional reg-
ulations in the provider country as well 
as facilitation of export permits.
3. The Provider has the right to request 
information on the state of the research 
from the User as agreed upon (see clause 
13 on Reporting).
Option 11.1
1. The following analyses, as set out in the 
project description, are performed in the 
provider country: 
[→   INSERT a list of analyses to be perfor-
med in the provider country].
2. The Provider confirms that all necessary 
conditions (equipment, staff and con-
sumables) for conducting the analyses 
are available;
3. The User confirms that he/she has the 
necessary resources (funding, time) for 
such an arrangement.
Option 11.2 
The Provider has the right to propose/
request the application for intellectual prop-
erty rights by the User. An ancillary agree-
ment providing for the regulation of owner-
ship, bearing of patent costs, income, and 
invention management will be negotiated. 
12  Rights and Obligations  
of the User 
1. The User is entitled to administrative 
support and guidance from the Provider 
to facilitate the acquisition of all other 
permits required by the providing coun-
try.
2. The User shall commercialize Products 
generated through the utilization of the 
Genetic Resources [and Associated Tra-
ditional Knowledge] only in accordance 
with the conditions agreed upon in this 
Agreement. 
3.  The User shall take all reasonable precau-
tions to prevent the Genetic Resources 
from coming into the possession of any 
Unauthorized Person. 
4. The User shall inform the Provider about 
any unforeseen research results that are 
of potential commercial interest, prior 
to publication or other disclosure of this 
information.
Option 12.1 
As the research implies Associated Tradi-
tional Knowledge, the User shall respect any 
relevant international law and the national 
and regional regulations in the provider 
country. The User shall proceed according to 
the indications of the Provider as foreseen 
in Annex [→  INSERT Annex XX]. He shall 
respect the customary law of the holders 
of the Associated Traditional Knowledge as 
listed in Annex [→  INSERT XX] and apply cur-
rent ethical standards.
 
 
Ad 12.4: If the Provider (in contrast to the 
User) has an interest in patenting the 
results, it is necessary to refrain from dis-
closing information (e.g. publishing research 
results in journals). It would impede the pro-
tection of the results by intellectual property 
rights due to the lack of novelty. 
The reference to international law regulating 
Associated Traditional Knowledge includes 
for example: 1948 Universal Declaration of 
Human Rights, International Labour Orga-
nization ILO Convention 169, The Declara-
tion on the Rights of Indigenous Peoples 
of the UN General Assembly (adopted 13 
September 2007). For ethical standards see 
e.g.: International Society of Ethnobiology 
(2006). ISE Code of Ethics (with 2008 addi-
tions). Online: http://ise.arts.ubc.ca/global_
coalition/ethics.php; Elements of a Code of 
Ethical Conduct to Ensure Respect for the 
Cultural and Intellectual Heritage of Indige-
nous and Local Communities. Report of the 
Sixth Meeting of the Ad Hoc Open-ended 
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inter-sessional Working Group on Article 8 (j) 
and related provisions of the Convention on 
Biological Diversity. UNEP/CBD/COP/10/2; 21 
November 2009.
It is a right and – according to the Nagoya 
Protocol – the duty of the Provider to instruct 
the User about the procedure for access to 
Associated Traditional Knowledge. Instruc-
tions can be included in this Agreement as 
its integral part, either through an additional 
clause stipulating the terms and conditions 
of use or annexed to the Agreement.
Such an ancillary contract will depend on the 
requirements of the relevant national law in 
the provider country regarding the obligation 
to conclude contracts with subnational enti-
ties (federal governmental bodies, Associated 
Traditional Knowledge holders, indigenous or 
local communities, private land owners)
 
For minimal requirements to be included in 
a contract with holders of Associated Tradi-
tional Knowledge, see Annex II.
The reporting may depend on the particular 
nature of the research and the interest of 
the Provider. He/she may request different 
amounts of information in a varying perio-
dicity. Therefore, we offer different options 
to meet the needs of the Parties, depending 
on the complexity of data included and the 
time schedule.
However, Parties may tailor any of these 
options to make it more suitable to their 
convenience or they can stipulate a new 
provision that will entirely reflect their 
needs. They are free to specify in a more 
 
 
Option 12.2 
Corresponding to national law the User 
will conclude an ancillary contract with the 
[holders of the Associated Traditional Knowl-
edge] [the private land owners].
 
13  Reporting
detailed manner the reasonable content and 
the structure of the report as well as the 
time period within which the report should 
be submitted.
 
Option 13.1
The User will deliver a written report in 
accordance with the Provider´s instruc-
tions as to its structure, information to be 
included, etc. upon his/her written request.
Option 13.2
The User shall submit to the Provider an 
annual written report on the research 
accomplished. The report is due on the 
[→  INSERT date].
Option 13.3
Upon request of the Provider, the User sub-
mits a written report on the research accom-
plished.
Option 13.4
The User submits an annual written report 
on the research accomplished. The report 
shall include a list of Third Parties to whom 
the Genetic Resources were transferred.
Option 13.5 
Since the Provider is a private citizen, upon 
his/her request, the report is translated into 
the local language by the User and adapted 
to a non-scientific audience. 
14  Publication
 
Option 14.1 
The User has the right to publish the results 
of the research related to the Genetic 
Resources [and Associated Traditional 
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Knowledge] utilized according to clause 4 
(Utilization) of the present Agreement, and 
according to good scientific practice. The 
source of the Genetic Resources [and of 
Associated Traditional Knowledge] has to be 
acknowledged.
Option 14.2 
For spiritual reasons; to prevent the deple-
tion of the genetic resources; and/or to pre-
vent unsafe or hazardous applications of 
the Associated Traditional Knowledge, the 
providing holder of Associated Traditional 
Knowledge requests confidentiality of the 
following specific information: 
[→  INSERT the information subject to confi-
dentiality].
Option 14.3
If the User, in the course of the research, 
discovers any unforeseen potential to uti-
lize the Genetic Resources [and Associated 
Traditional Knowledge] for commercial ends, 
he/she shall share on a confidential basis 
such information with the Provider prior to 
any publication of such information. 
Option 14.4
If the Provider intends to pursue a poten-
tial commercialization of an unforeseen 
discovery, this is subject to negotiations 
between the Provider and the User accord-
ing to Clauses 5 and 6 (Commercial Intent 
and Commercialization) and Clause 7, Option 
7.4 (intellectual property rights). The Provider 
agrees not to hold up the User’s research 
work unless concerns are concrete and jus-
tified in terms of well-defined proprietary 
interests.
This option takes account of the Provider’s 
concerns that published results may reduce 
his/her opportunity to derive commercial 
value from his/her Genetic Resources. On 
the other side, it takes account of the User’s 
interest that the Provider’s decision to com-
mercialize the results of the research does 
not significantly impede or delay the publi-
cation of the research results.
 
Option 14.5
If upon mutual agreement on the filing of 
a patent application in the interest of the 
Provider (Clause 7 Option 4) the User is pre-
vented from publishing the research results, 
the Provider agrees that the patent appli-
cation shall be filed within [→  INSERT XX] 
months. After the agreed period the User 
has the right to proceed with the publication 
of the research results.
15  Duration and Termination  
of the Agreement
1.  The present agreement is effective upon 
signature by both Parties and terminates 
upon completion of the research project 
with the provided Genetic Resources 
according to the project description 
[Annex XX] on [→  INSERT Date].
2.  It may be terminated at any time by 
mutual agreement of the Parties. 
3.  If a Party to the present Agreement wants 
to terminate the Agreement prior to the 
completion of the project, the Party shall 
give written notice [→  INSERT XX] months 
in advance.
4.  In the case of significant contract vio-
lations, both Parties shall have a right 
of termination for cause which shall be 
exercised within [→  INSERT XX] weeks 
from the notice of violation. 
Significant reasons for the Provider for 
exercising the right of termination for 
cause are e.g. [→  INSERT XX]. 
Significant reasons for the User for exer-
cising the right of termination for cause 
are e.g. [→  INSERT XX]. 
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The purpose of clause 15.5 is to preserve 
certain rights and obligations that are inde-
pendent of the duration or termination of 
the present Agreement as for instance stor-
age, handling of the Genetic Resources after 
termination of the Agreement. 
 
The Parties to the Agreement are free to 
establish competence of any court they 
agreed upon for potential disputes arising 
from the Agreement. They can also opt for 
arbitrage or to include any independent 
third party. 
The other side must be given a period of 
[→ INSERT XX] month[s] to comply with 
its contractual obligations.
5.  Clauses [→ INSERT XX] shall survive ter-
mination of the present Agreement. 
16  Handling of the Genetic  
Resources after Termination  
of the Agreement
 
Option 16.1
Upon termination of the Agreement, the 
Genetic Resources that have not been used 
up will be stored according to the terms of 
Utilization agreed under Clause 9. 
Option 16.2
If upon expiration of the Agreement or its 
termination the Genetic Resources have 
been deposited in e.g. an academic repos-
itory/stock center, the Genetic Resources 
shall be made available for Utilization under 
the same conditions as contained in this 
Agreement.
Option 16.3
Upon termination of the Agreement, the 
remaining Genetic Resources will be 
returned to the Provider. 
17  Settlement of Disputes
1. The Parties agree to make attempts in 
good faith to negotiate the resolution of 
any disputes that may arise under this 
Agreement. 
However, we believe that it is important that 
Parties seek to resolve any disputes in good 
faith before reverting to any court.
 
Parties may also include provisions on other 
matters of their importance and regulate 
issues such as warranties, force majeure, 
disclaimer.
Option 17.1
If the Parties are not able to resolve a dis-
pute within a period of [→  INSERT XX] 
months, such dispute shall be finally settled 
by an arbiter to be mutually agreed between 
the Parties [→  INSERT arbiter]. 
Option 17.2 
If the Parties are not able to resolve any 
dispute within a period of [XX] months, 
such dispute shall be resolved before the 
[→  INSERT XX] court law as the only com-
petent body for resolving disputes arising 
under this Agreement and in accordance 
with [→  INSERT applicable law; jurisdiction, 
language].
18  Other provisions
If any or more of the provisions of this 
Agreement become invalid or unenforce-
able in any respect, parties shall make a 
reasonable attempt to negotiate in good 
faith a provision which shall reflect the legal 
and economic substance of the invalid or 
unenforce able provision as closely as pos-
sible. 
If the invalidity of a provision of this Agree-
ment is not fundamental to its performance, 
the validity and enforceability of the remai-
ning provisions shall not in any way be 
affected.
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Annex I: Indicative list of benefits
 – Sharing of research and development 
results
 – Collaboration, cooperation and contribu-
tion in scientific research and develop-
ment programs, particularly biotechno-
logical research activities, where 
possible in the provider country
 – Performing certain analytical parts of the 
research in the provider country to the 
extent that adequate equipment is 
available and the user has the necessary 
resources (funding, time) for such 
arrangements
 – Participation in product development
 – Collaboration, cooperation and contribu-
tion in education and training
 – Admittance to ex-situ facilities of genetic 
resources and to databases
 – Transfer to  the  provider  of  the  genetic 
resources of knowledge and  technology  
under  fair and  most favorable terms, in 
particular, knowledge and technology 
that make use of genetic resources, 
including biotechnology, or that are 
relevant to the conservation  and 
sustainable  utilization of biological 
diversity
 – Facilitation of abilities of indigenous and 
local communities to conserve and 
sustainably use their genetic resources
 – Training related to genetic resources 
with the full participation of provider 
countries, and where possible, in such 
countries 
 – Access to scientific information relevant 
to conservation and sustainable use of 
biological diversity, including biological 
inventories and taxonomic studies
 – Contributions to the local economy
 – Research directed towards priority 
needs, such as health and food security, 
taking into account domestic uses of 
genetic resources in provider countries
 – Institutional and professional relation-
ships that may arise from an access and 
benefit-sharing agreement and 
subsequent collaborative activities
 – Food and livelihood security benefits
 – Social recognition
(adapted from the Convention on Biological 
Diversity and the Nagoya Protocol)
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Annex II: Suggested minimal requirements  
of a contract with holders of associated traditional 
knowledge 
In countries that are Party to the Nagoya 
Protocol, details of Prior Informed Consent 
of and Mutually Agreed Terms with the hold-
ers of Associated Traditional Knowledge 
might be defined by the National Competent 
Authority of the provider country, together 
with the indigenous and local communities. 
The National Competent Authority should be 
able to give the details.  
The Agreement contains some clauses spe-
cifically for the utilization of Associated Tra-
ditional Knowledge that may be integrated if 
the need arises. 
The contract with the holders of Associated 
Traditional Knowledge possibly needs to be 
edited in two languages. Define the main 
language.
To get Prior Informed Consent, prepare your-
self well for the negotiation with the hold-
ers of the Associated Traditional Knowledge. 
In particular the language of the explana-
tions about the research might need to be 
adapted (not English/Spanish/French; no 
scientific language). A translator might be 
needed. 
Suggested Elements 
User 
Name and coordinates of the research insti-
tution of the User; department responsible 
for the contract; name and coordinates of 
the researcher representing the institution.
Provider 
Name of the holders of Associated Tradi-
tional Knowledge/community; location of 
the community (region, name of location, 
village; coordinates); entity or person repre-
senting the holders of Associated Tradi-
tional Knowledge/community and entitled 
to negotiate and conclude a contract. 
Associated Traditional Knowledge 
 – Name(s) of the Genetic Resources 
(scientific, local) the Traditional Knowl-
edge is associated to. 
 – If Genetic Resources are collected: 
Location of collection; quantity to be 
collected; utilization made of resources; 
are the resources exported or not? 
Utilization of the resources after the 
conclusion of the project. 
 – Associated Traditional Knowledge: Raw 
description of the knowledge to be 
collected. 
 – Utilization of knowledge: Definition of 
knowledge that is confidential; or 
statement of procedure to define 
confidential knowledge once the results 
are produced. 
Research 
 – Description of research method 
(Observation, participation, interviews); 
definition of persons that can/cannot 
participate in the research. Analysis of 
data and publication. 
 – Results of research: For researcher; for 
the community. 
Benefits to be shared
For instance: information about results 
of the research in adapted form, lan-
guage and means; documentation of the 
traditional knowledge for the community; 
 capacity-building; engaging members 
of the community as guides, helpers in 
field-studies; teaching of young people to 
awaken interest for associated traditional 
knowledge. 
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Annex III: Basic Agreement on Access  
and Benefit-sharing for Academic Research
Preamble
The objective of this Model Agreement is to 
provide a sound basis for cooperation, trans-
parency, communication and trust between 
the parties to the Agreement, taking account 
of the concerns of both, Providers and Users 
of genetic resources. 
Its purpose is to define the Mutually Agreed 
Terms between its parties relating to access 
to and utilization of the Genetic Resources 
as well as the sharing of benefits resulting 
from their Utilization in accordance with the 
Nagoya Protocol to the Convention on Bio-
logical Diversity.                 
Parties to the Agreement 
The Agreement is entered into on  
 [→  INSERT the date] 
by and between
[→  INSERT the name and details  
of the following: 
 – State and Institution (competent ABS  
national authority, according to Article 13  
of the Nagoya Protocol and the domestic 
regulations of the Provider)
 – The contact person responsible for the 
implementation of the Agreement on 
behalf of the institution]
together hereinafter referred to as  
the “Provider”, and
[→  INSERT the name and details of 
 – The responsible research institution
 – The representative of the research 
institution responsible for the implemen-
tation of the Agreement]
Together hereinafter referred to as the 
“User”.
 
1 Use of Terms in the Agreement
This Agreement uses the terms as defined 
in Article 2 of the Nagoya Protocol, unless 
otherwise defined in this Agreement. 
1.1  Genetic Resources
Genetic Resources means any material of 
plant, animal, microbial or other origin con-
taining functional units of heredity and of 
actual or potential value (Article 2.10 of the 
Convention on Biological Diversity). 
1.2  Utilization of Genetic Resources
Utilization of Genetic Resources means to 
conduct research and development on the 
genetic and/or biochemical composition of 
genetic resources, including through the 
application of biotechnology (Article 2 (c) 
Nagoya Protocol). 
1.3  Derivatives
“Derivative” means a naturally occurring 
biochemical compound resulting from the 
genetic expression or metabolism of biolog-
ical or genetic resources, even if it does not 
contain functional units of heredity (Art 2 (e) 
Nagoya Protocol.
1.4 Commercial Intent 
Within the scope of this Agreement, Com-
mercial Intent is indicated by actions such 
as filing a patent application, obtaining 
intellectual property rights or other tangi-
ble or intangible rights; or the transfer of the 
Genetic Resources to a for-profit organiza-
tion.
1.5 Commercialization
Commercialization means the generation of 
any kind of economic benefits from utilized 
Genetic Resources [and/or Associated Tra-
ditional Knowledge]. It means in particular 
any sale, lease, licensing of utilized Genetic 
Resources, as well as applying for market 
admission/marketing of the Products gen-
erated thereof. 
1.6 Prior Informed Consent 
Prior Informed Consent means the unilateral 
declaration of the Provider that he/she has 
been informed about the planned research 
and that he/she is willing to provide the 
required access to Genetic Resources. 
1.7 Mutually Agreed Terms 
The Mutually Agreed Terms are an agree-
ment negotiated between the Provider and 
the User of the Genetic Resources [and/or 
holders of Traditional Knowledge associated 
to the Genetic Resources] according to the 
ABS regulatory requirements of the country 
providing the resources. The Mutually Agreed 
Terms regulate conditions for the access to 
the Genetic Resources [and/or to their Asso-
ciated Traditional Knowledge] and the fair and 
equitable sharing of benefits that result from 
their use. They are adapted to the specific 
access situation
1.8 Traditional Knowledge Associated  
 with Genetic Resources 
Associated Traditional Knowledge is knowl-
edge resulting from intellectual activity in a 
traditional context that is specific or gen-
eral in its relationship to genetic resources. 
It includes know-how, practices, skills and 
innovations. It can be found in a wide vari-
ety of contexts, including: agricultural knowl - 
edge; scientific knowledge, technical knowl-
edge, ecological knowledge, medicinal 
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knowledge, including related medicines and 
remedies; and biodiversity-related knowl-
edge.
1.9 Product
Product means the result produced, 
obtained, extracted or derived from the utili-
zation of the Genetic Resource [and Associ-
ated Traditional Knowledge] 
1.10 Provider
The Provider is the national competent 
authority designated according to Article 
13.2 of the Nagoya Protocol. In some cases 
the Provider might also be an institution 
established in accordance with domestic 
regulations of the provider country that is 
competent and responsible for the negoti-
ation and conclusion of this ABS contract. 
The provider is represented by the contact 
person responsible for the implementation 
of the Agreement on behalf of the institution.
1.11 User 
The User is the research institution respon-
sible for the execution of the research Pro-
ject. It may be represented by the person 
leading the project. 
1.12 Third Party
Third Party means any person or institution 
other than the Provider, the User and any 
collaborator under their control or supervi-
sion. 
1.13 Unauthorized Person
Unauthorized Person means any person 
that came into possession of the Genetic 
Resources without the authorization of the 
User.
2 Prior Informed Consent 
The Agreement is based on the Prior 
Informed Consent issued beforehand by 
the Provider to the User for the access to 
the genetic resources concerned. The doc-
ument on Prior Informed Consent [and the 
research project it is based on] is attached 
to this Agreement and is considered its inte-
gral part.  
3 Genetic Resources to be accessed
Insert the option that best suits your case. 
4 Utilization
Genetic Resources [and Associated Tra-
ditional Knowledge] may be utilized for 
non-commercial purposes including for 
academic research and collections, and for 
training, teaching and education.
5  Commercial Intent 
If the Utilization of the Genetic Resources 
[and Associated Traditional Knowledge] 
changes from non-commercial research to 
research with a Commercial Intent, such 
change requires a new Prior Informed Con-
sent in writing issued by the Provider. The 
terms for the new Utilization shall be subject 
to a separate agreement (Mutually Agreed 
Terms) between the involved parties.
6 Commercialization 
Any Commercialization of the Genetic 
Resources shall require a new Prior Informed 
Consent in writing issued by the Provider. 
The terms of such Commercialization shall 
be subject to a separate agreement (Mutu-
ally Agreed Terms) between the involved 
parties.  
7 Intellectual Property Rights 
The User shall not claim any intellectual 
property rights over the Genetic Resources 
[in the form received].
8 Transfer of Genetic Resources  
 [and Associated Traditional  
 Knowledge] to Third Parties 
Transfer of the Genetic Resources [and of 
Associated Traditional Knowledge] for the 
purposes of academic research and collec-
tions, and for training, teaching and edu-
cation, or any other non-commercial activ-
ities, is allowed under the condition that the 
User ensures that the subsequent person or 
institution (Third Party) is informed about the 
provisions under this Agreement and under-
takes to pass on the Genetic Resources [and 
Associated Traditional Knowledge] under the 
same obligations to any further recipient. 
9 Storage of Genetic Resources 
The User is entitled to deposit the Genetic 
Resources in collections that are accessible 
for the public as well as for research pur-
poses
10 Benefit-sharing
The following benefits arising from the uti-
lization of the Genetic Resources [and/or 
Associated Traditional Knowledge] shall be 
shared fairly and equitably by the User: 
 – Acknowledgment of the source of Genet-
ic Resources [and Associated Traditional 
Knowledge]  
 · In case of publication or oral pres-
entation of the research results, full 
acknowledgement shall be given to 
the source of the Genetic Resource. 
 · In the case of Associated Traditional 
Knowledge, the research results pub-
lished or presented orally will include 
full acknowledgement of the source, if 
so required by the Provider.
 – Sharing the results of the research 
 · The Provider will receive a copy of all 
publications. 
 · Research results will be communicat-
ed to involved stakeholders (e.g. com-
munities, indigenous people) in an 
adequate manner and according to 
reasonable requirements of the Pro-
vider;
 · Duplicate specimens will be shared 
with the repository in the provider 
country in accordance with good sci-
entific practice.
11 Rights and Obligations  
 of the Provider
1. The Provider is the responsible contact 
point for the User for the entire duration 
of the present Agreement. 
2. The Provider has the obligation to facili-
tate access to the Genetic Resources. This 
includes the facilitation of the acquisition 
of other permits required in accordance 
with the relevant national or regional reg-
ulations in the provider country as well 
as facilitation of export permits.
3. The Provider has the right to receive 
information on the state of the research 
from the User as agreed upon (see clause 
13 on Reporting).
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12 Rights and Obligations of the User
1. The User is entitled to administrative 
support and guidance from the Provider 
to facilitate the acquisition of all other 
permits required by the provider country.
2. The User shall commercialize Products 
generated through the utilization of the 
Genetic Resources [and Associated Tra-
ditional Knowledge] only in accordance 
with the conditions agreed upon in this 
Agreement. 
3. The User shall take all reasonable precau-
tions to prevent the Genetic Resources 
from coming into the possession of any 
Unauthorized Person. 
4. The User shall inform the Provider about 
any unforeseen research results that are 
of potential commercial interest, prior to 
publication or other disclosure of this 
information.
13 Reporting
Insert the option that best suits your case).
14 Publication
The User has the right to publish the results 
of the research related to the Genetic 
Resources [and Associated Traditional 
Knowledge] utilized according to clause 4 
(Utilization) of the present Agreement, and 
according to good scientific practice. The 
source of the Genetic Resources [and of 
Associated Traditional Knowledge] has to be 
acknowledged.
15 Duration and Termination  
 of the Agreement
1.  The present agreement is effective upon 
signature by both Parties and terminates 
upon completion of the research project 
with the provided Genetic Resources 
according to the project description 
[Annex XX] on [→  INSERT Date].
2.  It may be terminated at any time by 
mutual agreement of the Parties. 
3.  If a Party to the present Agreement wants 
to terminate the Agreement prior to the 
completion of the project, the Party shall 
give written notice [→  INSERT XX] months 
in advance.
4.  In the case of significant contract vio-
lations, both Parties shall have a right 
of termination for cause which shall be 
exercised within [→  INSERT XX] weeks 
from the notice of violation. 
 Significant reasons for the Provider for 
exercising the right of termination for 
cause are e.g. [→  INSERT XX]. Significant 
reasons for the User for exercising the 
right of termination for cause are e.g. 
[→  INSERT XX]. The other side must be 
given a period of [→  INSERT XX] month[s] 
to comply with its contractual obliga-
tions.
5. Clauses [→  INSERT XX] shall survive ter-
mination of the present Agreement.
16 Handling of the Genetic Resources  
 after Termination of the Agreement
Upon termination of the Agreement, the 
Genetic Resources that have not been used 
up will be stored according to the terms of 
Utilization agreed under Clause 9.
17 Settlement of Disputes
The Parties agree to make attempts in good 
faith to negotiate the resolution of any dis-
putes that may arise under this Agreement.
In addition, insert the option (p. xx) that best 
suits your intentions. 
18 Other provisions
If any or more of the provisions of this 
Agreement become invalid or unenforcea-
ble in any respect, parties shall make a rea-
sonable attempt to negotiate in good faith 
a provision which shall reflect the legal and 
economic substance of the invalid or unen-
forceable provision as closely as possible.
If the invalidity of a provision of this Agree-
ment is not fundamental to its performance, 
the validity and enforceability of the remain-
ing provisions shall not in any way be 
affected.
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Annex IV: ABS Elements to be included in an ABS 
compatible research permit for basic research 
If you do your research in a country that 
is a Party to the Convention on Biological 
Diversity but does not (yet) have ABS legis-
lation, regulatory requirements or a respec-
tive administrative organisation in place, 
and therefore is neither able to issue Prior 
Informed Consent, nor to negotiate Mutually 
Agreed Terms, you may want to suggest the 
inclusion of the following elements in your-
research permit: 
 –  Resources to be accessed (scientific 
name, place of collection)
 – Utilization of the resource (academic 
research, non-commercial, collections, 
training, teaching, education)
 – Intellectual Property Rights (no intellec-
tual property rights)
 –  Reporting obligations
 –  Benefits to be shared (e.g. cooperation 
with …; lectures; ….; employing local  
staff …).
This will increase your (legal) security 
 regarding ABS matters. It is also recom-
mended to document all the steps you 
have undertaken to observe possible ABS 
requirements, in order to have a proof in 
case of allegations of illegitimate access. 
Note that when accessing genetic resources 
or associated traditional knowledge in coun-
tries that are a Party only to the CBD, you 
don’t have an obligation to comply with the 
Swiss legislation on Due Diligence 1.
1 Compare Swiss Academies of Arts and Sciences 
(2016) Utilization of genetic resources and associ-
ated traditional knowledge in academic research. 
Swiss Academic Reports 11 (4), Bern, Switzerland.
Annex V: National Focal Point
Swiss National Focal Point to the Nagoya Protocol
Soil and Biotechnology Division
Federal Office for the Environment (FOEN)
3003 Bern
Switzerland
E-mail: contact.np@bafu.admin.ch 
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Who are we?
The Swiss Academies of Arts and Sciences link sciences regionally, nationally and internationally.  
They specifically engage in the fields of early warning and ethics and advocate for an equitable 
dialogue between science and society.
The Swiss Academies of Arts and Sciences is an association of the four Swiss scientific academies
– Swiss Academy of Sciences (SCNAT)
– Swiss Academy of Medical Sciences (SAMS)
– Swiss Academy of Humanities and Social Sciences (SAHS)
– Swiss Academy of Engineering Sciences (SATW) 
as well as the centres of competence 
– Centre for Technology Assessment (TA-SWISS) 
– Foundation Science et Cité 
SCNAT – network of knowledge for the benefit of society
The Swiss Academy of Sciences (SCNAT) and its network of 35 000 experts works at the regional, 
national and international level for the future of science and society. It strengthens the awareness for 
the sciences as a central pillar of cultural and economic development. The breadth of its support makes 
it a representative partner for politics. The SCNAT links the sciences, provides expertise, promotes the 
dialogue between science and society, identifies and evaluates scientific developments and lays the 
foundation for the next generation of natural scientists. It is part of the association of the Swiss 
Academies of Arts and Sciences. 
The Swiss Biodiversity Forum of the SCNAT is the scientific center of competence for biodiversity  
in Switzerland.
This manual contains a set of model clauses that enables users and providers of genetic resources and 
associated traditional knowledge to set up a contract that is adapted to the individual academic 
research situation. If mutually negotiated and agreed upon by the involved partners it can yield a 
“Mutually Agreed Terms” ABS contract.
The manual provides sectoral model contractual clauses for academic research in the sense of Article 
19.1 of the Nagoya Protocol. 

